CYCN (Cyclerion Therapeutics, Inc. Common Stock) Stock Analysis - Insider Trades

Cyclerion Therapeutics, Inc. Common Stock (CYCN) is a publicly traded Healthcare sector company. As of May 21, 2026, CYCN trades at $3.02 with a market cap of $13.08M and a P/E ratio of -2.27. CYCN moved +4.33% today. Year to date, CYCN is +123.19%; over the trailing twelve months it is -6.21%. Its 52-week range spans $1.03 to $9.47. Rallies surfaces CYCN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CYCN stock inside the company?

Recent CYCN insider activity includes Slate Path Capital LP sold 357.88K, MCGUIRE TERRANCE sold 8, MCGUIRE TERRANCE bought 92.83K, MCGUIRE TERRANCE bought 3.32K, and Hecht Peter M bought 823.17K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CYCN Key Metrics

Key financial metrics for CYCN
MetricValue
Price$3.02
Market Cap$13.08M
P/E Ratio-2.27
EPS$-1.36
Dividend Yield0.00%
52-Week High$9.47
52-Week Low$1.03
Volume42
Avg Volume0
Revenue (TTM)$1.99M
Net Income$-5.28M
Gross Margin0.00%

Recent CYCN Insider Trades

  • Slate Path Capital LP sold 357.88K (~$555.11K) on Nov 21, 2024.
  • MCGUIRE TERRANCE sold 8 (~$27.16) on Aug 9, 2023.
  • MCGUIRE TERRANCE bought 92.83K (~$289.63K) on Jun 3, 2021.
  • MCGUIRE TERRANCE bought 3.32K (~$10.36K) on Jun 3, 2021.
  • Hecht Peter M bought 823.17K (~$2.70M) on Jun 3, 2021.

Latest CYCN News

CYCN Analyst Consensus

CYCN analyst coverage data. Average price target: $0.00.

Common questions about CYCN

Who is trading CYCN stock inside the company?
Recent CYCN insider activity includes Slate Path Capital LP sold 357.88K, MCGUIRE TERRANCE sold 8, MCGUIRE TERRANCE bought 92.83K, MCGUIRE TERRANCE bought 3.32K, and Hecht Peter M bought 823.17K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CYCN?
Yes. Rallies tracks CYCN insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CYCN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CYCN. It does not provide personalized investment advice.
CYCN

CYCN